Nystatin
Based on 57 publication(s) in Google Scholar
Nystatin is an orally active polyene antifungal antibiotic effective against yeast and mycoplasma. Nystatin increases the permeability of plasma membranes to small monovalent ions, including chloridion. Nystatin is a cholesterol-sequestering agent, partially prevents Oxaliplatin-induced lipid raft aggregation, DR4 and DR5 clustering, and thereby reduces apoptosis.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.64%
- CAS. Nr.: 1400-61-9
- Formel: C47H75NO17
- Molecular Weight:926.09
-
Speicherung:
-20°C, sealed storage, away from moisture and light
* The compound is unstable in solutions, freshly prepared is recommended.
Publications Citing Use of MedChemExpress (MCE) Nystatin
More- Nat Nanotechnol. 2025 Feb;20(2):296-302. [Abstract]
- Adv Mater. 2026 Jun;38(33):e21108. [Abstract]
- Bioact Mater. 2026 Jun 17:65:644-662. [Abstract]
- Adv Funct Mater. 2024 Oct 31.
- Adv Funct Mater. 2020, 2004940.
- ACS Nano. 2025 Dec 26. [Abstract]
- Nat Commun. 2026 Jun 9. [Abstract]
- Nat Commun. 2025 Feb 4;16(1):1327. [Abstract]
- J Am Chem Soc. 2025 Oct 29;147(43):39912-39925. [Abstract]
- J Am Chem Soc. 2018 Dec 12;140(49):17234-17240. [Abstract]
- Bone Res. 2025 Oct 20;13(1):88. [Abstract]
- J Extracell Vesicles. 2026 Feb;15(2):e70238. [Abstract]
- Adv Sci (Weinh). 2023 Jul;10(19):e2301230. [Abstract]
- Biomaterials. 2022 Feb:281:121373. [Abstract]
- Biomaterials. 2021 Sep:276:121062. [Abstract]
- Carbohydr Polym. 2025 Jan 15;348(Pt A):122854. [Abstract]
- Redox Biol. 2025 May:82:103581. [Abstract]
- J Control Release. 2024 Oct 26:S0168-3659(24)00725-9. [Abstract]
- J Control Release. 2024 Aug 21:374:293-311. [Abstract]
- Biosens Bioelectron. 2025 Jan 25:274:117184. [Abstract]
- Mater Today Bio. 2025 Jul 10:33:102074. [Abstract]
- Sci China Life Sci. 2025 Oct 24. [Abstract]
- Sci China Life Sci. 2025 Feb 20. [Abstract]
- Sci China Life Sci. 2024 Dec;67(12):2713-2729. [Abstract]
- Sci China Life Sci. 2022 Feb;65(2):341-361. [Abstract]
- Small Methods. 2021 Apr;5(4):e2001047. [Abstract]
- Nano Lett. 2019 Nov 13;19(11):8010-8020. [Abstract]
- J Pharm Anal. 2025 Jul;15(7):101182. [Abstract]
- Int J Biol Macromol. 2025 Apr 28;310(Pt 4):143599. [Abstract]
- Int J Biol Macromol. 2025 Jun;311(Pt 2):143759. [Abstract]
- ACS Appl Mater Interfaces. 2025 Apr 17. [Abstract]
- Drug Deliv. 2025 Dec;32(1):2509962. [Abstract]
- Sci Total Environ. 2021 Jul 20:779:146523. [Abstract]
- Br J Pharmacol. 2023 Jul;180(14):1878-1896. [Abstract]
- Br J Pharmacol. 2020 Aug;177(15):3473-3488. [Abstract]
- Cell Death Discov. 2021 Feb 26;7(1):38. [Abstract]
- J Med Chem. 2026 Apr 9;69(7):8417-8432. [Abstract]
- Anal Chem. 2026 Feb 10;98(5):3577-3587. [Abstract]
- J Cell Biol. 2025 May 5;224(5):e202405060. [Abstract]
- Front Immunol. 2021 Aug 2;12:686846. [Abstract]
- Front Immunol. 2021 Sep 30:12:750128. [Abstract]
- Pharmaceutics. 2025 Nov 27;17(12):1524. [Abstract]
- ACS Appl Nano Mater. 2025 Mar 19.
- Int J Pharm. 2026 Jul 10:700:127037. [Abstract]
- Arab J Chem. 2020, 13 (1): 2558-2567.
- Mol Pharm. 2026 May 4;23(5):2944-2954. [Abstract]
- Mol Pharm. 2024 Mar 4;21(3):1149-1159. [Abstract]
- Front Cell Dev Biol. 2021 Mar 18:9:640667. [Abstract]
- J Biol Chem. 2022 May;298(5):101847. [Abstract]
- J Nutr. 2022 Aug 9;152(8):1991-2002. [Abstract]
- Microb Pathog. 2025 May 26:206:107751. [Abstract]
- Viruses. 2021 May 31;13(6):1035. [Abstract]
- Nanotoxicology. 2022 Nov-Dec;16(9-10):895-912. [Abstract]
- SSRN. 2025 Sep 30.
- University of Toronto. 2025.
- bioRxiv. 2025 Jun 9:2025.06.06.658366. [Abstract]
- bioRxiv. 2025 May 06.
-
Cell Proliferation/Viability Assay
-
WB
-
Flow Cytometry
-
Cell Imaging/Staining
-
Flow Cytometry
Alle Antibiotic Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Anti-fungal[1]
Nystatin results in a significant reduction in buccal epithelial cell adhesion of all six Candida species[1].
Nystatin is an antibiotic that increases the permeability of plasma membranes to small monovalent ions, including chloridion. Nystatin increases apical chloridion permeability to the point where transepithelial chloridion transport is limited by transport across the basolateral membrane of tracheal epithelial cells, which reflects primarily the activity of the cotransporter. Nystatin (400 units/mL) increases the basal level of transepithelial 36Cl flux approximately 1.5-fold and eliminates UTP stimulation of this flux. Nystatin treatment also abolishes UTP stimulation of saturable, basolateral [3H]bumetanide binding, a measure of functioning Na-K-Cl cotransporters in these cells; isoproterenol stimulation of binding is only mildly inhibited by nystatin treatment[2].
Nystatin significantly enhances endostatin uptake by endothelial cells through switching endostatin internalization predominantly to the clathrin-mediated pathway. Nystatin-enhanced internalization of endostatin also increases its inhibitory effects on endothelial cell tube formation and migration[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 1400-61-9
-
Appearance Solid
-
Molecular Weight 926.09
-
Formel C47H75NO17
-
Color Light yellow to khaki
-
SMILES
C[C@@H]1OC(C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@@](O)(O[C@H]2C[C@H](/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@@H]([C@@H](O)[C@H]1C)C)O[C@H]3[C@@H](O)[C@@H](N)[C@H](O)[C@@H](C)O3)C[C@H](O)[C@H]2C(O)=O)=O
-
Structure Classification
-
Initial Source
Streptomyces noursei B3
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
-20°C, sealed storage, away from moisture and light
* The compound is unstable in solutions, freshly prepared is recommended.
Publications (57)
-
Journal Impact Factor
-
Most Recent
-
Nat Nanotechnol
2025 Feb;20(2):296-302. PMID: 39468359
Nystatin purchased from MedChemExpress. Usage Cited in: Nat Nanotechnol. 2025 Feb;20(2):296-302. [Abstract]
EGFR degradation in MDA-MB-231 cells after incubation with 500 nM NTZ-NPs and 5 μM Nystatin for 24 h.
-
Adv Mater
Conformationally Variable Peptides Trap and Detoxify Ox-LDL in Plaques for Attenuating Atherosclerosis in Multiple Species. [Abstract]2026 Jun;38(33):e21108. PMID: 42116761 -
Bioact Mater
Growth plate cartilage-targeting nanoparticles for pharmacological treatment of hypochondroplasia. [Abstract]2026 Jun 17:65:644-662. PMID: 42338508 -
-
Nystatin purchased from MedChemExpress. Usage Cited in: Adv Funct Mater. 2020, 2004940.
Endocytosis analysis of MUSE with endocytosis inhibitors (chloroquine, chloropromazine, Nystatin (50 µg/mL; 1 h), wortmannin) by FCM and CLSM.
-
ACS Nano
Redox-Responsive Peptide Coacervates for Enhanced mRNA Delivery and Intracellular Release. [Abstract]2025 Dec 26. PMID: 41451635 -
Nat Commun
2026 Jun 9. PMID: 42259798 -
Nat Commun
Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism. [Abstract]2025 Feb 4;16(1):1327. PMID: 39900573 -
J Am Chem Soc
Hijacking Extracellular Targeted Protein Degrader-Drug Conjugates for Enhanced Drug Delivery. [Abstract]2025 Oct 29;147(43):39912-39925. PMID: 41091621
Nystatin purchased from MedChemExpress. Usage Cited in: J Am Chem Soc. 2025 Oct 29;147(43):39912-39925. [Abstract]
Cytotoxicity of 0.8 nM DDCs on A431 cells in the presence of 50 nM BafA, 50 nM MG132, and 1 μM Nystatin, respectively. Cells treated with inhibitors alone showed no cytotoxicity at the concentrations used in DDC treatments. Dead cells were labeled by 1 μg/mL propidium iodide after 48 h of treatment.
-
J Am Chem Soc
2018 Dec 12;140(49):17234-17240. PMID: 30398334
Nystatin purchased from MedChemExpress. Usage Cited in: J Am Chem Soc. 2018 Dec 12;140(49):17234-17240. [Abstract]
Cells were pretreated for 0.5 h with the indicated inhibitor (e.g., Nystatin, 25 μg/mL) to 2 h treatment with 2 μM K4-GFP in the continued presence of inhibitor, washed, and analyzed by flow cytometry. Treatment at 4 °C instead of 37 °C was included as a control (blue bars).
-
Bone Res
Pak4-mediated crosstalk between necroptotic macrophages and tendon stem/progenitor cells contributes to traumatic heterotopic ossification formation. [Abstract]2025 Oct 20;13(1):88. PMID: 41111094 -
J Extracell Vesicles
Extracellular Vesicles Coordinate Bacterial Cloaking in Lung Epithelial Cells to Alleviate Acute Inflammatory Injury. [Abstract]2026 Feb;15(2):e70238. PMID: 41656978 -
Adv Sci (Weinh)
Dual Functioned Hexapeptide-Coated Lipid-Core Nanomicelles Suppress Toll-Like Receptor-Mediated Inflammatory Responses through Endotoxin Scavenging and Endosomal pH Modulation. [Abstract]2023 Jul;10(19):e2301230. PMID: 37078808 -
Biomaterials
Oral delivery of decanoic acid conjugated plant protein shell incorporating hybrid nanosystem leverage intestinal absorption of polyphenols. [Abstract]2022 Feb:281:121373. PMID: 35063742
Nystatin purchased from MedChemExpress. Usage Cited in: Biomaterials. 2022 Feb:281:121373. [Abstract]
Flow cytometry quantitation of cellular uptake of NR-EA-PLN(C/S) by analyzing NR fluorescence intensity for various incubation conditions. Caco-2 cells were cultured in the flask and incubated at 4 °C or 37 °C with endocytosis inhibitors (EIPA, Cytochalasin-D, Nystatin (11 μM) and Chlorpromazine) for 2 h. The NR concentration was 3.57 μg/mL.
-
Biomaterials
2021 Sep:276:121062. PMID: 34418816 -
Carbohydr Polym
Dextran-based nanodrugs with mitochondrial targeting/glutathione depleting synergy for enhanced photodynamic therapy. [Abstract]2025 Jan 15;348(Pt A):122854. PMID: 39562123 -
Redox Biol
AGR2-mediated cell-cell communication controls the antiviral immune response by promoting the thiol oxidation of TRAF3. [Abstract]2025 May:82:103581. PMID: 40085973 -
J Control Release
2024 Oct 26:S0168-3659(24)00725-9. PMID: 39490420 -
J Control Release
Enhanced delivery of CRISPR/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy. [Abstract]2024 Aug 21:374:293-311. PMID: 39151831 -
Biosens Bioelectron
Cathepsin B dependent activatable trigger fluorophore (CAT-Fluor) for in situ functional imaging of antibody-drug conjugates. [Abstract]2025 Jan 25:274:117184. PMID: 39879789 -
Mater Today Bio
Hyaluronic acid-anchored nanoparticles co-delivering emodin and siRNA confers protection against rheumatoid arthritis via macrophage polarization. [Abstract]2025 Jul 10:33:102074. PMID: 40688667 -
Sci China Life Sci
Receptor affinity-selective differential dynamics of membrane fusion initiation govern deltacoronavirus cross-species transmission. [Abstract]2025 Oct 24. PMID: 41144156 -
Sci China Life Sci
2025 Feb 20. PMID: 39985646 -
Sci China Life Sci
Bactericidal ability of target acidic phospholipids and phagocytosis of CDC42 GTPase-mediated cytoskeletal rearrangement underlie functional conservation of CXCL12 in vertebrates. [Abstract]2024 Dec;67(12):2713-2729. PMID: 39279006 -
Sci China Life Sci
2022 Feb;65(2):341-361. PMID: 34047913 -
Small Methods
2021 Apr;5(4):e2001047. PMID: 34927842 -
Nano Lett
2019 Nov 13;19(11):8010-8020. PMID: 31639306 -
J Pharm Anal
Effect of cholesterol on distribution, cell uptake, and protein corona of lipid microspheres at sites of cardiovascular inflammatory injury. [Abstract]2025 Jul;15(7):101182. PMID: 40735031 -
Int J Biol Macromol
2025 Apr 28;310(Pt 4):143599. PMID: 40306505 -
Int J Biol Macromol
A dual-peptides and specific promoter-modified nano gene delivery system for myocardial hypertrophy treatment. [Abstract]2025 Jun;311(Pt 2):143759. PMID: 40319986 -
ACS Appl Mater Interfaces
Fullerol Initiates Stem Cell-Nanomaterials Interactions for Enhanced Tissue Regeneration via Clathrin-Mediated Endocytosis and Nuclear Factor Erythroid 2-Related Factor 2 Signaling. [Abstract]2025 Apr 17. PMID: 40241445 -
Drug Deliv
Ophthalmic formulation of methotrexate: a strategy of using the self-assembled LacAC4A nanoparticles for non-invasive drug delivery to the ocular posterior segment. [Abstract]2025 Dec;32(1):2509962. PMID: 40437914 -
Sci Total Environ
2021 Jul 20:779:146523. PMID: 34030247 -
Br J Pharmacol
2023 Jul;180(14):1878-1896. PMID: 36727262 -
Br J Pharmacol
An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db/db mice. [Abstract]2020 Aug;177(15):3473-3488. PMID: 32293707 -
Cell Death Discov
Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer. [Abstract]2021 Feb 26;7(1):38. PMID: 33637695 -
J Med Chem
Hsp70-Targeting Chimeras Enable Dual Proteasomal and Lysosomal Degradation of Intracellular and Extracellular Proteins. [Abstract]2026 Apr 9;69(7):8417-8432. PMID: 41874277 -
Anal Chem
Fluorogenic Peptide-Modulated 2D ZnO/MnO2 Nanosheet Heterostructure Enables Monitoring of Tumor Early Response to Immunotherapy. [Abstract]2026 Feb 10;98(5):3577-3587. PMID: 41603436 -
J Cell Biol
2025 May 5;224(5):e202405060. PMID: 40136051 -
Front Immunol
Mannose Receptor Mediates the Activation of Chitooligosaccharides on Blunt Snout Bream ( Megalobrama amblycephala) Macrophages. [Abstract]2021 Aug 2;12:686846. PMID: 34408745 -
Front Immunol
The Modulatory Activity of Tryptophan Displaying Nanodevices on Macrophage Activation for Preventing Acute Lung Injury. [Abstract]2021 Sep 30:12:750128. PMID: 34659253 -
Pharmaceutics
CC-90009, a Cereblon E3 Ligase Modulator, Exhibits Antiviral Efficacy Against JEV In Vitro and In Vivo via Targeted Degradation of GSPT1 and Viral NS5 Protein. [Abstract]2025 Nov 27;17(12):1524. PMID: 41471039 -
-
Int J Pharm
Novel Gemini surfactant-polyglutamic acid composite system enhances DNA delivery via a "Dual-Engine" uptake strategy. [Abstract]2026 Jul 10:700:127037. PMID: 42217812 -
-
Mol Pharm
2026 May 4;23(5):2944-2954. PMID: 41931102 -
Mol Pharm
2024 Mar 4;21(3):1149-1159. PMID: 38288708 -
Front Cell Dev Biol
Structural and Functional Characterization of Fibronectin in Extracellular Vesicles From Hepatocytes. [Abstract]2021 Mar 18:9:640667. PMID: 33816490 -
J Biol Chem
Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice. [Abstract]2022 May;298(5):101847. PMID: 35314195 -
J Nutr
Docosahexaenoic Acid Ameliorates the Toll-Like Receptor 22-Triggered Inflammation in Fish by Disrupting Lipid Raft Formation. [Abstract]2022 Aug 9;152(8):1991-2002. PMID: 35679100 -
Microb Pathog
EIPA, A macropinocytosis blocking agent, inhibits Siniperca chuatsi rhabdovirus infection in vitro and in vivo. [Abstract]2025 May 26:206:107751. PMID: 40436219 -
Viruses
Bovine Parainfluenza Virus Type 3 (BPIV3) Enters HeLa Cells via Clathrin-Mediated Endocytosis in a Cholesterol- and Dynamin-Dependent Manner. [Abstract]2021 May 31;13(6):1035. PMID: 34072688 -
Nanotoxicology
Evaluation of cytotoxicity and biodistribution of mesoporous carbon nanotubes (pristine/-OH/-COOH) to HepG2 cells in vitro and healthy mice in vivo. [Abstract]2022 Nov-Dec;16(9-10):895-912. PMID: 36704847 -
-
-
bioRxiv
Low-density lipoprotein receptor-targeting chimeras for membrane protein degradation and enhanced drug delivery. [Abstract]2025 Jun 9:2025.06.06.658366. PMID: 40661577 -
Lösungsmittel & Löslichkeit
DMSO : 50 mg/mL (53.99 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: 2.5 mg/mL (2.70 mM); Suspended solution; Need ultrasonic
This protocol yields a suspended solution of 2.5 mg/mL. Suspended solution can be used for oral and intraperitoneal injection.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (2.70 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * The compound is unstable in solutions, freshly prepared is recommended.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (281 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Ellepola AN, et al. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol. 1999 Dec;14(6):358-63. [Content Brief]
[2]. Haas M, et al. Na-K-Cl cotransport in nystatin-treated tracheal cells: regulation by isoproterenol, apical UTP, and [Cl]i. Am J Physiol. 1994 May;266(5 Pt 1):C1440-52. [Content Brief]
[3]. Chen Y, et al. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood. 2011 Jun 9;117(23):6392-403 [Content Brief]
[4]. Wallace TL, et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43 [Content Brief]
[5]. Xu L, et al. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.FEBS Lett. 2009 Mar 4;583(5):943-8. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.0798 mL | 5.3990 mL | 10.7981 mL | 26.9952 mL |
| 5 mM | 0.2160 mL | 1.0798 mL | 2.1596 mL | 5.3990 mL | |
| 10 mM | 0.1080 mL | 0.5399 mL | 1.0798 mL | 2.6995 mL | |
| 15 mM | 0.0720 mL | 0.3599 mL | 0.7199 mL | 1.7997 mL | |
| 20 mM | 0.0540 mL | 0.2700 mL | 0.5399 mL | 1.3498 mL | |
| 25 mM | 0.0432 mL | 0.2160 mL | 0.4319 mL | 1.0798 mL | |
| 30 mM | 0.0360 mL | 0.1800 mL | 0.3599 mL | 0.8998 mL | |
| 40 mM | 0.0270 mL | 0.1350 mL | 0.2700 mL | 0.6749 mL | |
| 50 mM | 0.0216 mL | 0.1080 mL | 0.2160 mL | 0.5399 mL |